STRO
Sutro Biopharma
16.00$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -22.0% | -71.7% | 33.0% | -152.2% | -158.7% | -132.0% | 5.2% | -72.6% | -308.7% | -172.9% | |
| 9.5% | 9.6% | 11.8% | 11.2% | 10.1% | 7.8% | 8.4% | 4.4% | 11.6% | 7.1% | |
| 1.6% | 2.7% | 7.5% | 24.1% | 27.9% | 37.6% | 38.8% | 16.2% | 39.8% | 13.7% | |
| 1.9% | 8.8% | 7.9% | 25.0% | -66.7% | 59.2% | 18.7% | – | – | – | |
| -36.3% | -52.0% | 110.9% | -54.4% | -26.9% | -28.5% | 154.1% | -22.4% | 14.3% | -49.2% | |
| 7.4% | 6.4% | 4.1% | 8.1% | 16.7% | 24.8% | 11.6% | 2.8% | 5.0% | 1.7% | |
| 16.1% | 63.0% | -208.7% | -119.6% | 1.4% | -157.3% | -51.7% | -2.6% | 352.2% | 43.9% | |
| – | – | – | 0.7% | 0.7% | – | 0.7% | – | – | – | |
| 0.3% | 29.2% | 219.8% | -0.8% | -0.7% | 0.0% | -0.7% | -0.3% | – | – | |
| 25.1% | 29.0% | -13.0% | -11.7% | 35.1% | -15.2% | -13.8% | -8.1% | -6.6% | 0.0% | |
| 0.3% | 28.3% | 444.5% | -9.8% | 630.2% | 5.3% | 71.3% | 89.5% | 151.6% | 0.0% | |
| -5.7% | 19.6% | 268.8% | -281.6% | 472.9% | -284.0% | 24.8% | 14.3% | 195.1% | -129.0% | |
| -29.4% | -78.1% | 29.0% | -160.3% | -175.4% | -156.8% | -6.4% | -75.4% | -313.7% | -174.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.